Our biomarker team at the Brain and Mind Centre (BMC) undertakes technical and scientific operations for the collection, preparation, archiving and analysis of blood and other biospecimen samples from patients for the development of biomarkers. The overall aim of the program is identify unique profiles of proteins, lipids, endogenous retroviruses and other molecular markers that can be measured and used to accurately distinguish different pathological forms of dementia from each other, particularly different types of frontotemporal temporal dementia, and other neurodegenerative diseases. At the same time, we conduct biochemical and pathological research to pinpoint and understand perturbed pathways underlying neurodegenerative diseases.